Hexos 75 mg/ml (Trenbolone Hexahydrobenzyl Carbonate)
Hexos 75 mg/ml (Trenbolone Hexahydrobenzyl Carbonate) – Driada Medical
Hexos 75 mg/ml by Driada Medical is a premium long-acting anabolic agent containing Trenbolone Hexahydrobenzylcarbonate, historically recognized in elite bodybuilding circles under the trade name Parabolan. Engineered for advanced athletes, powerlifters, and bodybuilders, Hexos delivers unparalleled muscle hypertrophy, dense muscular hardness, and dramatic strength increases without fluid retention.
Available at steroidseu.com for just 52.00 EUR, every batch of Driada Medical Hexos undergoes rigorous third-party verification and is Janoshik Lab Tested to guarantee exact dosing and chemical purity.
Product Profile
The table below summarizes the key pharmacological and biological attributes of Hexos 75 mg/ml:
| Product Parameter | Specification |
|---|---|
| Active Substance | Trenbolone Hexahydrobenzylcarbonate |
| Dosage / Concentration | 75 mg/ml |
| Form | Injectable solution |
| Category | Injectable Steroids / Anabolic Steroid |
| Anabolic Activity | 500% of Testosterone |
| Androgenic Activity | 500% of Testosterone |
| Active Half-Life | 10–14 days |
| Aromatization | No |
| Hepatotoxicity | Low |
| Manufacturer | Driada Medical (Janoshik Lab Tested) |
| Product Price | 52.00 EUR |
Key Benefits & Pharmacological Effects
Due to its high anabolic rating of 500%, Hexos is one of the most potent compounds in the category of Trenbolone derivatives. Athletes utilize Hexos to accomplish dramatic body recomposition and peak contest conditioning.
- Substantial Lean Muscle Mass: Promotes rapid protein synthesis and nitrogen retention without subcutaneous water bloat, producing dense and dry muscle tissue.
- Enhanced Rate of Fat Oxidation: Binds strongly to androgen receptors, promoting lipolysis and allowing bodybuilders to shed body fat while preserving lean tissue during calorie deficits.
- Increased IGF-1 Levels: Significantly elevates systemic Insulin-like Growth Factor-1, enhancing recovery, joint repair, and cell proliferation.
- Zero Estrogenic Conversion: Trenbolone Hexahydrobenzylcarbonate does not aromatize into estrogen, eliminating direct estrogen-induced gynecomastia and liquid retention.
- Long-Sustained Blood Levels: The hexahydrobenzylcarbonate ester provides a extended half-life of 10 to 14 days, minimizing injection frequency compared to acetate esters.
Dosage & Cycle Protocols
Because of its immense potency, dosing should be calculated carefully based on user experience and target goals. Hexos is typically administered via deep intramuscular injection once or twice per week.
Recommended Dosage Protocols
- Intermediate Dosage: 150 mg to 225 mg per week (2 to 3 ml per week). This range provides exceptional strength and hypertrophy gains while minimizing risk.
- Advanced Dosage: 300 mg per week (4 ml per week). Reserved strictly for competitive bodybuilders with substantial compound experience.
- Cycle Duration: 8 to 12 weeks. Prolonged cycles beyond 12 weeks are not recommended due to HPTA suppression.
Effective Stacking Options
To prevent loss of libido and hormonal imbalance, Hexos should always be stacked with an exogenous testosterone base, such as Testosterone Enanthate. For cutting and hardening, Hexos stacks exceptionally well with non-aromatizing agents such as Masteron or oral agents like Anavar.
Side Effect Management & Post Cycle Therapy (PCT)
While Hexos possesses low hepatotoxicity and zero aromatization, its high progestogenic and androgenic potency requires proactive on-cycle management and planned recovery.
- Prolactin Control: Trenbolone exhibits strong progestogenic activity, which can elevate serum prolactin. Keep Cabergoline on hand to manage potential prolactin-related side effects.
- Estrogen Management: While Hexos itself does not aromatize, stacking it with aromatizing testosterones requires maintaining Aromatase Inhibitors to keep baseline estrogen under control.
- Endogenous Suppression & PCT: Hexos strongly suppresses the HPTA axis. A thorough Post Cycle Therapy (PCT) protocol using Clomid or Nolvadex is mandatory starting approximately 2 to 3 weeks after the final injection.
Why Buy Hexos 75 mg/ml from steroidseu.com?
When purchasing high-grade pharmacology, source authenticity is critical. Here is why ordering from steroidseu.com ensures complete confidence:
- Janoshik Lab Tested Quality: Driada Medical products undergo rigorous analytical testing to guarantee active ingredient concentration and chemical purity.
- Competitive Pricing: Direct distribution guarantees genuine Hexos 75 mg/ml at an accessible price point of 52.00 EUR.
Frequently Asked Questions (FAQ)
1. How does Hexos differ from Trenbolone Acetate?
Hexos contains Trenbolone attached to the Hexahydrobenzylcarbonate ester, giving it a longer half-life (10–14 days) compared to Trenbolone Acetate (1.5–2 days). This allows for less frequent injections while maintaining stable blood levels.
2. How often should Hexos 75 mg/ml be injected?
Due to its long half-life, Hexos can be injected once every 5 to 7 days, or split into two equal weekly injections (e.g., Monday and Thursday) to maintain perfectly peak hormone levels.
3. Is Post Cycle Therapy required after running a Hexos cycle?
Yes, absolutely. Trenbolone hexahydrobenzylcarbonate causes significant suppression of natural testosterone production. A structured PCT using selective estrogen receptor modulators (SERMs) like Clomid should begin 14–21 days after your last injection.
© Original content by steroidseu.com
Medical Disclaimer: The information provided in this description is intended strictly for educational and scientific research purposes and does not constitute formal medical advice, diagnosis, or treatment protocols. Anabolic steroids are potent pharmacological agents capable of producing significant cardiovascular, hormonal, and psychological side effects. Always consult with a licensed healthcare professional before considering any anabolic administration or dietary regime. steroidseu.com does not advocate or encourage the unauthorized use of prescription medicines without appropriate medical supervision.
this product yet